CEFORT 500mg powder for injection / infusion solution medication leaflet

J01DD04 ceftriaxone • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins

Ceftriaxone is a third-generation cephalosporin antibiotic used to treat severe bacterial infections, including meningitis, pneumonia, intra-abdominal infections, urinary tract infections, and sepsis. It is effective against a wide range of gram-negative and gram-positive bacteria.

The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Ceftriaxone is frequently used in hospitals for complicated infections or for patients at high risk of severe infections.

Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or liver toxicity. It is important for patients to complete the treatment as directed by their doctor.

Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as anaphylactic shock or hematological disorders. Patients should inform their doctor of any unusual symptoms.

General data about CEFORT 500mg

Substance: ceftriaxone

Date of last drug list: 01-07-2014

Commercial code: W13890006

Concentration: 500mg

Pharmaceutical form: powder for injection / infusion solution

Quantity: 50

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ANTIBIOTICE SA - ROMANIA

Holder: ANTIBIOTICE SA - ROMANIA

Number: 6269/2014/06

Shelf life: 3 years

Concentrations available for ceftriaxone

0.5g, 1000mg, 1g, 250mg, 2g, 500mg